Science & Technology Watch
SEE OTHER BRANDS

Your science and technology news reporter

Science & Technology Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science & Technology Watch.

Press releases published on July 29, 2025

Rakovina Therapeutics Announces Stock Option Grants

Rakovina Therapeutics Announces Stock Option Grants

VANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: RKV) (FSE: 7JO0) (the “Company” or “Rakovina”), a biopharmaceutical company advancing cancer therapies through artificial intelligence (AI)-powered drug …

Firefly Awarded $177 Million NASA Contract for Mission to the Moon’s South Pole

Firefly Awarded $177 Million NASA Contract for Mission to the Moon’s South Pole

CEDAR PARK, Texas, July 29, 2025 (GLOBE NEWSWIRE) -- Firefly Aerospace, a market leading space and defense technology company, was awarded a $176.7 million NASA Commercial Lunar Payload Services (CLPS) contract to deliver five NASA-sponsored payloads to …

Portland Med Spa Expands Service Offerings with Latest Aesthetic Technologies

Portland Med Spa Expands Service Offerings with Latest Aesthetic Technologies

Residents of Portland now have exclusive access to a premier lineup of innovative aesthetic treatments designed to rejuvenate, refresh, and restore confidence. PORTLAND, OR, UNITED STATES, July 29, 2025 /⁨EINPresswire.com⁩/ -- From cutting-edge anti-aging …

Kadant Reports Second Quarter 2025 Results

Kadant Reports Second Quarter 2025 Results

WESTFORD, Mass., July 29, 2025 (GLOBE NEWSWIRE) -- Kadant Inc. (NYSE: KAI) reported its financial results for the second quarter ended June 28, 2025. Second Quarter Financial Highlights Bookings increased 7% to $269 million Revenue decreased 7% to $255 …

Vinmec Central Park Performs Vietnam’s First Pediatric SEEG with AutoGuide Robot

Vinmec Central Park Performs Vietnam’s First Pediatric SEEG with AutoGuide Robot

HO CHI MINH CITY, VIETNAM, July 29, 2025 /⁨EINPresswire.com⁩/ -- A major breakthrough in Vietnam’s neurological treatment was recently achieved as doctors at Vinmec Central Park International Hospital successfully performed surgery on a 9-year-old boy with …

Enovation in IOL Material: VSY Biotechnology’s Enova® Premium IOLs Set New Standard with 100% Glistening Free Technology

Enovation in IOL Material: VSY Biotechnology’s Enova® Premium IOLs Set New Standard with 100% Glistening Free Technology

LEINFELDEN-ECHTERDINGEN, GERMANY, July 29, 2025 /⁨EINPresswire.com⁩/ -- VSY Biotechnology GmbH’s groundbreaking Enova® intraocular lens is reshaping expectations in the ophthalmic industry. As the first and only 100% glistening-free hydrophobic acrylic IOL …

Capital Power announces a 6% dividend increase for its common shares and declares dividends for its Preference shares

Capital Power announces a 6% dividend increase for its common shares and declares dividends for its Preference shares

EDMONTON, Alberta, July 29, 2025 (GLOBE NEWSWIRE) -- The Board of Directors for Capital Power Corporation (“Capital Power”) (TSX: CPX) declared a dividend of $0.6910 per share on the outstanding common shares for the quarter ending September 30, 2025. The …

Counterpart Health Appoints Vicky Bruner as Vice President of Operations to Support Expansion and Customer Execution

Counterpart Health Appoints Vicky Bruner as Vice President of Operations to Support Expansion and Customer Execution

WILMINGTON, Del., July 29, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) and a leading AI-powered physician- …

Nick Stanage Joins HII Board of Directors

Nick Stanage Joins HII Board of Directors

NEWPORT NEWS, Va., July 29, 2025 (GLOBE NEWSWIRE) -- HII (NYSE: HII) announced today that former chairman, CEO and president of Hexcel Corporation Nick Stanage was elected to the company’s board of directors. “We are pleased to welcome Nick to the board of …

Axonius Acquires Medical Device Security Specialist Cynerio for More Than $100 Million to Target Healthcare Market

Axonius Acquires Medical Device Security Specialist Cynerio for More Than $100 Million to Target Healthcare Market

NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- Axonius, the global leader in cyber asset intelligence, today announced that it has acquired Cynerio, a pioneer in medical device security for more than $100 million in a cash and stock transaction. The …

InterDigital and Samsung conclude arbitration and announce new license agreement

InterDigital and Samsung conclude arbitration and announce new license agreement

WILMINGTON, Del., July 29, 2025 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a mobile, video and AI technology research and development company, today announced that its arbitration with Samsung Electronics has concluded and that the two …

Silvaco to Acquire Mixel, Inc. a Provider of Low-Power, High-Performance Mixed-Signal Connectivity IP Solutions

Silvaco to Acquire Mixel, Inc. a Provider of Low-Power, High-Performance Mixed-Signal Connectivity IP Solutions

SANTA CLARA, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Silvaco Group, Inc. (“Silvaco”) (NASDAQ: SVCO), a provider of TCAD, EDA software, and SIP solutions that enable semiconductor design and digital twin modeling through AI software and innovation, today …

100th Fisher House Dedicated at Lovell Federal Health Care Center

100th Fisher House Dedicated at Lovell Federal Health Care Center

North Chicago, IL, July 29, 2025 (GLOBE NEWSWIRE) -- A new Fisher House was dedicated at the Captain James A. Lovell Federal Health Care Center (Lovell FHCC) by Lovell FHCC Director Dr. Robert Buckley, Deputy Director, Commanding Officer NMRTC Great Lakes …

DBV Technologies announces filing of 2025 Half-Year Report ― Conditions for accessing or consulting the Report

DBV Technologies announces filing of 2025 Half-Year Report ― Conditions for accessing or consulting the Report

Châtillon, France, July 29, 2025 DBV Technologies announces filing of 2025 Half-Year Report ― Conditions for accessing or consulting the Report DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage …

DBV Technologies publie son Rapport Financier Semestriel 2025 ― Modalités de mise à disposition ou de consultation

DBV Technologies publie son Rapport Financier Semestriel 2025 ― Modalités de mise à disposition ou de consultation

Châtillon, France, le 29 juillet 2025 DBV Technologies publie son Rapport Financier Semestriel 2025 ― Modalités de mise à disposition ou de consultation DBV Technologies (Euronext : DBV – ISIN : FR0010417345 - Nasdaq : DBVT), une société biopharmaceutique …

Bioventus to Report Second Quarter of Fiscal Year 2025 Financial Results on August 6, 2025

Bioventus to Report Second Quarter of Fiscal Year 2025 Financial Results on August 6, 2025

DURHAM, N.C., July 29, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the second quarter of fiscal year 2025 …

DBV Technologies Reports Second Quarter and Half-Year 2025 Financial Results

DBV Technologies Reports Second Quarter and Half-Year 2025 Financial Results

Châtillon, France, July 29, 2025 DBV Technologies Reports Second Quarter and Half-Year 2025 Financial Results DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP: 23306J309), a clinical-stage biopharmaceutical company, …

DBV Technologies publie ses résultats financiers du 2ème trimestre et 1er semestre 2025

DBV Technologies publie ses résultats financiers du 2ème trimestre et 1er semestre 2025

Châtillon, France, le 29 juillet 2025 DBV Technologies publie ses résultats financiers du 2ème trimestre et 1er semestre 2025 DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq Stock Market : DBVT-CUSIP : 23306J309), société biopharmaceutique …

Cardiff Oncology Announces Positive Data from Ongoing Randomized Phase 2 First-line RAS-mutated mCRC Clinical Trial (CRDF-004)

Cardiff Oncology Announces Positive Data from Ongoing Randomized Phase 2 First-line RAS-mutated mCRC Clinical Trial (CRDF-004)

– Trial demonstrates 49% confirmed ORR in the 30mg onvansertib dose arm versus 30% confirmed ORR in the control arm in intent-to-treat population (N=110) – – Early PFS data show a trend favoring 30mg onvansertib dose arm vs. control arm – – Onvansertib …

Pulmonx to Present at the Canaccord Genuity 45th Annual Growth Conference

Pulmonx to Present at the Canaccord Genuity 45th Annual Growth Conference

REDWOOD CITY, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced the company will be presenting at the Canaccord …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions